Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3) reported that on September 30, 2026, it received the resignation of Paulo Roberto Belem Junior from the position of member of the company’s Board of Directors.

Since the current Board of Directors was elected through the multiple voting system, the resignation makes a new election of the board members necessary, which will be resolved at the next Extraordinary General Shareholders’ Meeting to be called.

Source: Material Fact, filed with the CVM on 10/01/2026 08:30. View original document

For information only; not investment advice.

Is ONCO3 worth investing in?

ONCO3Oncoclínicas · B3
Price
R$ 0.81
as of 11/13/2026
Dividend yield
0.00 %
P/L
N/A
P/VPA
55.87
View full analysis of ONCO3